Mark Klempner

UMassMed Faculty Page

Inventions:

Title: Broadly Borreliacidal Human Monoclonal Antibodies to OspA and their Uses. UMMS15-03; Patent Pending. 

• The invention provides anti-OspA antibodies and methods of use as a pre-exposure prophylactic against all three pathogenic Borrelia species causing Lyme disease. 

  • Inventors: Biologics
    
  • Applications: Infectious Disease, Borrelia, Borreliacidal/lyme, Human monoclonal, Antibody

Innovation Topics: Biologics, Infectious Disease, Borrelia, Borreliacidal/lyme, Human monoclonal, Antibody